| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 10/03/2006 | CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 10/03/2006 | CA2288241C Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 09/28/2006 | WO2006101859A2 Piperidinyl substituted cyclohexane-1,4-diamines |
| 09/28/2006 | WO2006101245A1 N-substituted-n-(4-piperidinyl) amide derivative |
| 09/28/2006 | WO2006100586A1 Glycosidase-inhibiting iminosugars |
| 09/28/2006 | WO2006100099A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 09/28/2006 | WO2006066747A8 4-aminopiperidine derivatives |
| 09/28/2006 | WO2006060731A3 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 |
| 09/28/2006 | WO2006055321A3 Process of making fentanyl intermediates |
| 09/28/2006 | WO2006037047A3 The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents |
| 09/28/2006 | US20060217560 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens |
| 09/28/2006 | US20060217557 Polymorphic form XVI of fexofenadine hydrochloride |
| 09/28/2006 | US20060217534 Bis (amino acid) molecular scaffolds |
| 09/28/2006 | US20060217467 Salt-like reaction products of hals derivatives and carboxylic acids for the stabilisation of polymeric materials |
| 09/28/2006 | US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| 09/28/2006 | US20060217419 e.g. N-cis-{4-[4-(2-isopropoxy-phenyl)-piperidin-1-yl]-cyclohexyl}-3,4-dimethoxy-benzenesulfonamide; adrenoreceptor antagonist; benign prostatic hypertrophy and lower urinary tract symptoms |
| 09/28/2006 | US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 09/28/2006 | US20060217403 Substituted 2-aminoacetamides and the use thereof |
| 09/28/2006 | US20060216754 Prepared via a combinatorial synthesis based on a Suzuki coupling, subsequent halo-demetallation and finally a Suzuki coupling; Suzuki couplings are each carried out with a boronic acid or a boronic acid ester; 5-Bromo-1,3-difluoro-2-[(R)-3-methylpentyl]benzene |
| 09/28/2006 | CA2602112A1 Sulfonyl containing compounds as cysteine protease inhibitors |
| 09/28/2006 | CA2598969A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1705176A1 Carboxamide derivative and use thereof |
| 09/27/2006 | EP1704856A1 Hsp90 family protein inhibitor |
| 09/27/2006 | EP1704146A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 09/27/2006 | EP1594840B1 Piperidine-benzenesulfonamide derivatives |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | CN1839121A Hydroxamic acid compounds and methods of use thereof |
| 09/27/2006 | CN1276914C Novel cyclohexyl sulphones |
| 09/26/2006 | US7112594 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents |
| 09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
| 09/26/2006 | CA2278694C Sulfamide-metalloprotease inhibitors |
| 09/21/2006 | WO2006099167A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099166A1 Crystalline forms of a biphenyl compound |
| 09/21/2006 | WO2006099165A1 Crystalline forms of a biphenyl compound |
| 09/21/2006 | WO2006099091A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099060A2 Process for the preparation of opioid modulators |
| 09/21/2006 | WO2006099032A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099031A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098999A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098997A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098982A1 Process for the preparation of opioid modulators |
| 09/21/2006 | WO2006097848A1 Hiv-1 virion maturation inhibitors, compositions and treatments using the same |
| 09/21/2006 | WO2006097730A1 Analogues of the azinomycins as anti-tumour agents and as prodrugs |
| 09/21/2006 | WO2006097460A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | WO2006097341A1 Process for making crystalline donepezil hydrochloride monohydrate |
| 09/21/2006 | WO2006097175A1 Dpp-iv inhibitors |
| 09/21/2006 | WO2006097169A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 09/21/2006 | WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 09/21/2006 | WO2006047330A3 Methylphenidate analogs and methods of use thereof |
| 09/21/2006 | WO2006034092A3 Process for production of piperidine derivatives |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | US20060211864 Methods for the stereoselective synthesis of substituted piperidines |
| 09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
| 09/21/2006 | US20060211742 having a purity of at least 95% pure, preferably at least about 97% pure, more preferably at least at least about 99.5% pure; providing rapid relief from hypertension |
| 09/21/2006 | US20060211736 Glutarimide-containing polyketide analogs and methods thereof |
| 09/21/2006 | US20060211735 4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 09/21/2006 | US20060211734 (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists |
| 09/21/2006 | US20060211731 New substituted pyridine or piperidine compounds |
| 09/21/2006 | US20060211728 Thalidomide analogs |
| 09/21/2006 | US20060211722 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | US20060211097 Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives |
| 09/21/2006 | DE102005011050A1 Verfahren zur Herstellung von 1-Aminopiperidinderivaten A process for the preparation of 1-aminopiperidine derivatives |
| 09/21/2006 | CA2602173A1 Dpp-iv inhibitors |
| 09/21/2006 | CA2601674A1 Process for the preparation of opioid modulators |
| 09/21/2006 | CA2601481A1 Process for the preparation of opioid modulators |
| 09/21/2006 | CA2600904A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 09/21/2006 | CA2600528A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | CA2599236A1 Crystalline forms of a biphenyl compound |
| 09/20/2006 | EP1702916A1 DPP-IV inhibitors |
| 09/20/2006 | EP1701951A2 Modulators of peripheral 5-ht receptors |
| 09/20/2006 | EP1701939A1 Anthraquinone compounds as anti cancer compounds |
| 09/20/2006 | EP1246801B1 Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 09/20/2006 | CN1835751A Therapeutic agents useful for treating pain |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/20/2006 | CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109310 Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs |
| 09/19/2006 | US7109217 Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 09/19/2006 | US7109215 Compounds possessing neuronal activity |
| 09/19/2006 | US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 09/19/2006 | US7109208 Rho kinase inhibitors having axon of the retinal ganglion cellal extension- and optic nerve cell regeneration- promoting action, particularly (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide |
| 09/14/2006 | WO2006095822A1 Sulfonamide compound and pharmaceutical thereof |
| 09/14/2006 | WO2006095723A1 Antiallergic drug |
| 09/14/2006 | WO2006095568A1 Process for oxidation of organic compounds |
| 09/14/2006 | WO2006095020A1 Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 09/14/2006 | WO2006094763A1 3,4,5-substituted piperidine compounds |
| 09/14/2006 | WO2006094633A1 1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus |
| 09/14/2006 | WO2006094602A1 Indane |
| 09/14/2006 | WO2006094395A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | US20060205954 Process for the hydrogenation of aromatic compounds |
| 09/14/2006 | US20060205953 Isotopically labeled chemically stable reagents and process for the synthesis thereof |
| 09/14/2006 | US20060205847 Lactone-added hindered amine compound |
| 09/14/2006 | US20060205782 Method of providing an antihistaminic effect in a hepatically impaired patient |
| 09/14/2006 | US20060205781 Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 09/14/2006 | US20060205780 Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 09/14/2006 | US20060205779 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(5-[4-(3-dimethylaminopropoxy)benzylamino]pentylcarbamoyl)ethyl)piperidin-4-yl ester |